|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-11-12
|
|
pubmed:abstractText |
Recently, a novel device for measuring the cardio-ankle vascular index (CAVI) as an arterial stiffness parameter has been developed. In this study, we evaluated the effect of angiotensin II receptor blocker (ARB) and calcium channel (Ca) blocker on CAVI in type 2 diabetic patients with hypertension.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/8-hydroxy-2'-deoxyguanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Amlodipine,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyguanosine,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/olmesartan
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1880-3873
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
621-6
|
|
pubmed:dateRevised |
2010-4-6
|
|
pubmed:meshHeading |
pubmed-meshheading:19907103-Aged,
pubmed-meshheading:19907103-Amlodipine,
pubmed-meshheading:19907103-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:19907103-Ankle,
pubmed-meshheading:19907103-Antihypertensive Agents,
pubmed-meshheading:19907103-Body Weight,
pubmed-meshheading:19907103-Calcium Channel Blockers,
pubmed-meshheading:19907103-Deoxyguanosine,
pubmed-meshheading:19907103-Diabetes Mellitus, Type 2,
pubmed-meshheading:19907103-Drug Therapy, Combination,
pubmed-meshheading:19907103-Female,
pubmed-meshheading:19907103-Hemoglobin A, Glycosylated,
pubmed-meshheading:19907103-Humans,
pubmed-meshheading:19907103-Hypertension,
pubmed-meshheading:19907103-Imidazoles,
pubmed-meshheading:19907103-Lipids,
pubmed-meshheading:19907103-Male,
pubmed-meshheading:19907103-Middle Aged,
pubmed-meshheading:19907103-Tetrazoles
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension.
|
|
pubmed:affiliation |
Department of Internal Medicine, Sakura Medical Center, School of Medicine, Toho University, Japan. mumon@sf6.so-net.ne.jp
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
